The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISTH 2022 | The importance of investigating the bone marrow microenvironment in precursor stages of myeloma
Xue-Yan Cui
• 11 Jul 2022
Xue-Yan Cui, MD, PhD, Oslo University Hospital, Oslo, Norway, briefly explains how a better understanding of the bone marrow microenvironment in precursor stages of myeloma can improve treatment approaches and possibly prevent disease progression. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
